| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $185.8M | -54.2% |
| Cost of Revenue | $106.4M | -54.5% |
| Gross Profit | $79.4M | -53.7% |
| R&D Expense | $26.0M | -22.8% |
| SG&A Expense | $46.2M | -20.6% |
| Operating Income | -$28.3M | -186.4% |
| Pre-tax Income | -$16.0M | -128.4% |
| Income Tax | $1.8M | -30.9% |
| Net Income | -$19.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $267.8M | -7.8% |
| Accounts Receivable | $23.8M | -40.7% |
| Inventory | $34.2M | -28.2% |
| Current Assets | $333.2M | -13.8% |
| Total Assets | $479.7M | -0.7% |
| Current Liabilities | $33.5M | -15.3% |
| Total Liabilities | $69.3M | +32.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.4M | -80.7% |
| Capital Expenditures | $3.8M | -34.6% |
| Investing Cash Flow | -$39.0M | -159.0% |
| Financing Cash Flow | -$4.2M | -38.1% |
| Free Cash Flow | $23.6M | -82.6% |
| -136.3% |
| EPS (Basic) | -$0.26 | -135.6% |
| EPS (Diluted) | -$0.26 | -136.1% |
| Stockholders' Equity |
| $410.3M |
| -4.7% |